Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

חו"ל (דורש נסיעה)פעיל (ללא גיוס)PHASE2

מצבים רפואיים

Postural Orthostatic Tachycardia Syndrome (POTS)

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Mercy Gilbert Medical Center, Gilbert, Arizona, United States

  • North County Neurology Associates, Carlsbad, California, United States

  • Stanford University, Palo Alto, California, United States

  • Southern California Heart Specialists, Pasadena, California, United States

  • Yale University, New Haven, Connecticut, United States

  • Innovative Research of West Florida, Inc., Clearwater, Florida, United States

  • Indiana University Health Neuroscience Center, Indianapolis, Indiana, United States

  • Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States

  • Mayo Clinic, Rochester, Minnesota, United States

  • Saint Luke's MidAmerica Heart Institute, Kansas City, Missouri, United States

  • New York University Langone, New York, New York, United States

  • University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States

  • Vanderbilt University Medical Center, Nashville, Tennessee, United States

  • University of Texas Southwestern, Dallas, Texas, United States

  • University of Utah, Salt Lake City, Utah, United States

  • University of Calgary, Calgary, Alberta, Canada

מובילי המחקר
  • Clinical Trial Management

    Study Director

    Regeneron Pharmaceuticals